Loading the SOTA2 catalog…
Mutation-specific organoid platform for drug screening.
Mutation-specific organoid platform for drug screening. Uses micropatterned 2.5D organoids from disease-specific hiPSCs to model genetic diseases, with support for cardiac, hepatic, neural (in progress), and kidney (in progress) organoid types.
Platforms, integrations, and language support vary by plan and region. Confirm final requirements with the vendor.
Loading community reviews…
Compliance claims are normalized from current vendor documentation and independently reviewed by SOTA2.